bretylium has been researched along with neuropeptide y in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CF; Chen, HI; Cheng, JT; Shum, AY; Wang, JY | 1 |
| Brain, KL; Cunnane, TC | 1 |
2 other study(ies) available for bretylium and neuropeptide y
| Article | Year |
|---|---|
Increase of plasma neuropeptide Y-like immunoreactivity following chronic hypoxia in the rat.
Topics: Adrenal Glands; Adrenalectomy; Animals; Blood Pressure; Bretylium Compounds; Chromatography, High Pressure Liquid; Female; Guanethidine; Hypoxia; Male; Neuropeptide Y; Norepinephrine; Radioimmunoassay; Rats; Rats, Inbred Strains | 1992 |
Bretylium abolishes neurotransmitter release without necessarily abolishing the nerve terminal action potential in sympathetic terminals.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Bretylium Compounds; Calcium Signaling; Catecholamines; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Neuropeptide Y; Neurotransmitter Agents; Presynaptic Terminals; Sympathetic Nervous System; Synaptic Transmission; Time Factors; Vas Deferens | 2008 |